Platform Technology Partners’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$41K Sell
2022
Q2
$146K Buy
2022
Q1
$320K Sell
2021
Q4
$657K Buy
2021
Q3
$713K Sell
2021
Q2
$853K Buy
2020
Q4
$474K Buy
2020
Q3
$326K Buy
2020
Q2
$248K Buy
2020
Q1
$115K Buy